Group 1: Product Development and Market Competitiveness - The new generation of high-end bone-integrated implants is expected to complete product registration within this year, significantly enhancing the company's market competitiveness in the oral field [1][2] - The product features hydrophilic sandblasting and acid washing surface treatment to increase bone integration strength, improving adaptability and stability for different bone conditions [2][3] Group 2: Financial Performance - Revenue from other products increased from 9 million to 16 million, a growth of 700 thousand, with 330 thousand attributed to the PEEK material sternum fixation belt [3] - The increase in revenue also includes contributions from maxillofacial repair products and supporting surgical tools [3]
康拓医疗(688314) - 西安康拓医疗技术股份有限公司投资者关系活动记录表(2024年半年度业绩说明会)